Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors.

MLA

Floriana Morgillo, et al. “Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors.” PLoS ONE, vol. 6, no. 12, Jan. 2011, p. e28841. EBSCOhost, https://doi.org/10.1371/journal.pone.0028841.

APA

Floriana Morgillo, Erika Martinelli, Teresa Troiani, Michele Orditura, Ferdinando De Vita, & Fortunato Ciardiello. (2011). Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors. PLoS ONE, 6(12), e28841. https://doi.org/10.1371/journal.pone.0028841

Chicago

Floriana Morgillo, Erika Martinelli, Teresa Troiani, Michele Orditura, Ferdinando De Vita, and Fortunato Ciardiello. 2011. “Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors.” PLoS ONE 6 (12): e28841. doi:10.1371/journal.pone.0028841.